Found: 117
Select item for more details and to access through your institution.
Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5617, doi. 10.1002/alz.14073
- By:
- Publication type:
- Article
Development and validation of an algorithm for identifying urinary retention in a cohort of patients with epilepsy in a large US administrative claims database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 4, p. 413, doi. 10.1002/pds.3975
- By:
- Publication type:
- Article
Risk of cancer in patients exposed to gabapentin in two electronic medical record systems.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2012, v. 21, n. 2, p. 214, doi. 10.1002/pds.2266
- By:
- Publication type:
- Article
Exploring differential prescribing between anti-epileptic drugs in epilepsy patients with a history of mood disorders.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2010, v. 19, n. 3, p. 289, doi. 10.1002/pds.1905
- By:
- Publication type:
- Article
Genetic Deficiency of Plasma Lipoprotein-Associated Phospholipase A<sub>2</sub> (PLA2G7 V297F Null Mutation) and Risk of Alzheimer's Disease in Japan.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 21, n. 3, p. 775, doi. 10.3233/JAD-2010-100513
- By:
- Publication type:
- Article
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study.
- Published in:
- Alzheimer's Research & Therapy, 2022, p. 1, doi. 10.1186/s13195-022-01124-2
- By:
- Publication type:
- Article
Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01129-x
- By:
- Publication type:
- Article
Evaluation of tau deposition using <sup>18</sup>F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01048-x
- By:
- Publication type:
- Article
Lewy Body Dementia Association's Industry Advisory Council: proceedings of the second annual meeting.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00868-7
- By:
- Publication type:
- Article
Plasma lipoprotein-associated phospholipase A<sub>2</sub> activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study.
- Published in:
- Alzheimer's Research & Therapy, 2012, v. 4, n. 6, p. 1, doi. 10.1186/alzrt154
- By:
- Publication type:
- Article
Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo‐Controlled, Double‐Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease.
- Published in:
- Annals of Neurology, 2024, v. 95, n. 2, p. 288, doi. 10.1002/ana.26819
- By:
- Publication type:
- Article
Tratamiento contributivo de los pagos recibidos como indemnización por conceptos de daños morales y angustias mentales.
- Published in:
- Revista de Derecho Puertorriqueño, 2007, v. 47, n. 1, p. 149
- By:
- Publication type:
- Article
Clinical and neuropathological features of dementia with Lewy bodies.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 1998, v. 13, n. 6, p. 284, doi. 10.1177/153331759801300603
- By:
- Publication type:
- Article
Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
- Published in:
- Acta Neuropathologica, 2007, v. 114, n. 5, p. 471, doi. 10.1007/s00401-007-0280-z
- By:
- Publication type:
- Article
No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer’s disease brain.
- Published in:
- Acta Neuropathologica, 2006, v. 112, n. 4, p. 439, doi. 10.1007/s00401-006-0095-3
- By:
- Publication type:
- Article
Alpha-synuclein has an altered conformation and shows a tight intermolecular interaction with ubiquitin in Lewy bodies.
- Published in:
- Acta Neuropathologica, 2001, v. 102, n. 4, p. 329, doi. 10.1007/s004010100369
- By:
- Publication type:
- Article
Plasma Urate and Progression of Mild Cognitive Impairment.
- Published in:
- Neurodegenerative Diseases, 2008, v. 6, n. 1/2, p. 23, doi. 10.1159/000170883
- By:
- Publication type:
- Article
Prevalence and Effects of Lobar Microhemorrhages in Early-Stage Dementia.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 6, p. 305, doi. 10.1159/000092317
- By:
- Publication type:
- Article
Apolipoprotein E modulates γ-secretase cleavage of the amyloid precursor protein.
- Published in:
- Journal of Neurochemistry, 2004, v. 90, n. 5, p. 1132, doi. 10.1111/j.1471-4159.2004.02581.x
- By:
- Publication type:
- Article
ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2023, v. 9, n. 1, p. 1, doi. 10.1002/trc2.12377
- By:
- Publication type:
- Article
An exploration of cognitive subgroups in Alzheimer's disease.
- Published in:
- Journal of the International Neuropsychological Society, 2010, v. 16, n. 2, p. 233, doi. 10.1017/S1355617709991160
- By:
- Publication type:
- Article
Initial exploration of a brain age score based on validated computerized cognitive assessments in Japanese individuals: Neuropsychology/Multicultural issues in assessment of dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045446
- By:
- Publication type:
- Article
AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer's disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial): Clinical trial design and implementation
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044511
- By:
- Publication type:
- Article
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 1, p. 131, doi. 10.1016/j.jalz.2019.06.4956
- By:
- Publication type:
- Article
DT‐01‐01: BAN2401 IN EARLY ALZHEIMER'S DISEASE: NEURODEGENERATION BIOMARKER ANALYSIS FROM A RANDOMIZED PHASE 2 STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1484, doi. 10.1016/j.jalz.2019.08.004
- By:
- Publication type:
- Article
P1‐048: PLASMA NF‐L AS A BIOMARKER FOR NEURODEGENERATION IN MILD AD SUBJECTS IN THE PHASE 2 NAVIGATE‐AD STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P251, doi. 10.1016/j.jalz.2019.06.073
- By:
- Publication type:
- Article
P4‐388: TRAILBLAZER‐ALZ (NCT03367403): A PHASE 2 DISEASE‐MODIFICATION COMBINATION THERAPY TRIAL TARGETING MULTIPLE MECHANISMS OF ACTION ALONG THE AMYLOID PATHWAY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1622, doi. 10.1016/j.jalz.2018.07.212
- By:
- Publication type:
- Article
O3‐13‐02: LOBAR CLASSIFICATION OF TAU PET IMAGES IN THE EXPEDITION‐3 TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1055, doi. 10.1016/j.jalz.2018.06.2844
- By:
- Publication type:
- Article
P1‐326: THE USE OF THE DIGITAL CLOCK DRAWING TEST (DCTCLOCK™) IN THE SCREENING PHASE OF CLINICAL TRIALS FOR ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P416, doi. 10.1016/j.jalz.2018.06.333
- By:
- Publication type:
- Article
O1‐09‐01: SIGNIFICANT AND SUSTAINED FLORBETAPIR F18 UPTAKE REDUCTION IN PATIENTS WITH SYMPTOMATIC ALZHEIMER'S DISEASE WITH LY3002813, A β‐AMYLOID PLAQUE‐SPECIFIC ANTIBODY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P239, doi. 10.1016/j.jalz.2018.06.2378
- By:
- Publication type:
- Article
IC‐P‐216: LOBAR CLASSIFICATION OF TAU PET IMAGES IN THE EXPEDITION‐3 TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P177, doi. 10.1016/j.jalz.2018.06.2283
- By:
- Publication type:
- Article
TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY SUBJECTS OF SINGLE DOSES OF LY2599666, AN ANTIGEN BINDING FRAGMENT (FAB) OF A MONOCLONAL ANTIBODY THAT TARGETS SOLUBLE MONOMER Aβ LINKED TO A POLY(ETHYLENE GLYCOL) MOLECULE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P250, doi. 10.1016/j.jalz.2017.06.108
- By:
- Publication type:
- Article
PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY, AND TOLERABILITY OF LY3202626, A NOVEL BACE1 INHIBITOR, IN HEALTHY SUBJECTS AND PATIENTS WITH ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P418, doi. 10.1016/j.jalz.2016.06.791
- By:
- Publication type:
- Article
COMBINATION THERAPY WITH A PLAQUE-SPECIFIC ABETA ANTIBODY AND A BACE INHIBITOR RESULTS IN DRAMATIC PLAQUE REDUCTION IN A DOSE-DEPENDENT MANNER IN AGED PDAPP TRANSGENIC MICE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1191, doi. 10.1016/j.jalz.2016.07.146
- By:
- Publication type:
- Article
SAFETY, PHARMACOKINETICS (PK), AND FLORBETAPIR F-18 POSITRON EMISSION TOMOGRAPHY (PET) AFTER MULTIPLE DOSE ADMINISTRATION OF LY3002813, A β-AMYLOID PLAQUE-SPECIFIC ANTIBODY, IN ALZHEIMER’S DISEASE (AD).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P352, doi. 10.1016/j.jalz.2016.06.665
- By:
- Publication type:
- Article
Investigation of dose-responses and longitudinal effects of combination therapy with a plaque-specific amyloid beta antibody and bace inhibitor in aged transgenic mice.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P275, doi. 10.1016/j.jalz.2015.07.364
- By:
- Publication type:
- Article
The epidemiology of Alzheimer’s disease: Laying the foundation for drug design, conduct, and analysis of clinical trials
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Modeling Alzheimer’s disease progression using the disease system analysis approach
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2012, v. 8, n. 1, p. 39, doi. 10.1016/j.jalz.2010.12.012
- By:
- Publication type:
- Article
Lipoprotein-associated phospholipase A2 (Lp-PLA2) and risk of dementia in the cardiovascular health study
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Determination of a specific lipoprotein-associated phospholipase A2 activity in human cerebrospinal fluid
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Correlates of plasma lipoprotein phopsholipase A2 (Lp-PLA2) activity in Alzheimer's disease (AD), mild cognitive impairment (MCI), and cognitively healthy elderly
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Genetic deficiency of plasma lipoprotein-associated phospholipase A2 (Lp-PLA<sub>2</sub>) and risk of Alzheimer's disease in Japan
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Safety and tolerability of rosiglitazone XR in a randomised, placebo-controlled study in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P4-373: Predictors of placebo group decline in the Alzheimer's disease assessment scale-cognitive subscale (ADAS-cog) in 24-week clinical trials of Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P4-108: Serum cystatin C and the risk of Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P3-222: Genetic regulation of Aβ levels in human plasma
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P3-076: CSF Tau levels and APOEϵ4 carriership predict the progression of mild cognitive impairment to Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P4-294: In vivo effects of a gamma secretase inhibitor on plaque size and dendritic curvature monitored longitudinally with multiphoton microscopy
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P4-079: Coordinated expression of APP pathway mRNA and protein in AD
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P3-100: Longitudinal changes in plasma Aβ42 positively correlate with progression of mild cognitive impairment
- Published in:
- 2006
- By:
- Publication type:
- Abstract